(S)-2-(6-Benzhydrylpyridin-2-yl)-4-isobutyl-4,5-dihydrooxazole, 97%, 250mg

N-(tert-Butoxycarbonyl)-2-(2-aminoethoxy)ethylamine>95.0%(GC)200mg

Bis(2,4-pentanedionato)magnesium(II)>98.0%(T)5g

GC capillary column ROTI®Cap-5 MS Ultra, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

2-(4-Chlorobenzoyl)benzoic acid, 95.0%, 1kg

N-(5-methyl-7-oxo-4,5,6-trihydrobenzothiazol-2-yl)ethanamide, 98%, 2g

[3,3'-Bipyridin]-6-amine, 95.0%, 250mg

tert-Butyl N-(1H-1,2,3-benzotriazol-1-ylmethyl)-N-(2-phenylethyl)carbamate, 95.0%, 50mg

4-Chlorothieno[3,2-d]pyrimidine-6-carbaldehyde, 95.0%, 1g

1-Heptyl-1H-1,2,3-benzotriazole, 98.0%, 250mg

1-Aminocyclopentanecarboxylic Acid>98.0%(T)5g

tert-butyl 2,8-diazaspiro[4.6]undecane-2-carboxylate hydrochloride, 95.0%, 1g

3,5-dimethyl-3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g